These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12548564)

  • 1. TRANCE together with IL-7 induces pre-B cells to proliferate.
    Kato I; Sato H; Kudo A
    Eur J Immunol; 2003 Feb; 33(2):334-41. PubMed ID: 12548564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells.
    Josien R; Wong BR; Li HL; Steinman RM; Choi Y
    J Immunol; 1999 Mar; 162(5):2562-8. PubMed ID: 10072496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
    Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K
    J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
    Wada N; Maeda H; Yoshimine Y; Akamine A
    Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
    J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
    Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
    Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.
    Sordillo EM; Pearse RN
    Cancer; 2003 Feb; 97(3 Suppl):802-12. PubMed ID: 12548579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of kappa L chain gene rearrangements and c-kit and IL-7 receptor expression in stromal cell-dependent pre-B cells.
    Henderson AJ; Narayanan R; Collins L; Dorshkind K
    J Immunol; 1992 Sep; 149(6):1973-9. PubMed ID: 1381391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin is expressed in colon carcinoma cells.
    Pettersen I; Bakkelund W; Smedsrød B; Sveinbjørnsson B
    Anticancer Res; 2005; 25(6B):3809-16. PubMed ID: 16309167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of early B lymphocyte precursors in transgenic mice overexpressing the murine heat-stable antigen.
    Hough MR; Chappel MS; Sauvageau G; Takei F; Kay R; Humphries RK
    J Immunol; 1996 Jan; 156(2):479-88. PubMed ID: 8543797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKC eta directs induction of IRF-4 expression and Ig kappa gene rearrangement in pre-BCR signaling pathway.
    Oda A; Ono T; Yamamoto M; Goitsuka R; Kitamura D
    Int Immunol; 2008 Nov; 20(11):1417-26. PubMed ID: 18780722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF receptor type 1 regulates RANK ligand expression by stromal cells and modulates osteoclastogenesis.
    Abu-Amer Y; Abbas S; Hirayama T
    J Cell Biochem; 2004 Nov; 93(5):980-9. PubMed ID: 15389885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
    Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
    Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma arrests proliferation and causes apoptosis in stromal cell/interleukin-7-dependent normal murine pre-B cell lines and clones in vitro, but does not induce differentiation to surface immunoglobulin-positive B cells.
    Grawunder U; Melchers F; Rolink A
    Eur J Immunol; 1993 Feb; 23(2):544-51. PubMed ID: 8436185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression.
    Marshall AJ; Fleming HE; Wu GE; Paige CJ
    J Immunol; 1998 Dec; 161(11):6038-45. PubMed ID: 9834086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.
    Kong YY; Yoshida H; Sarosi I; Tan HL; Timms E; Capparelli C; Morony S; Oliveira-dos-Santos AJ; Van G; Itie A; Khoo W; Wakeham A; Dunstan CR; Lacey DL; Mak TW; Boyle WJ; Penninger JM
    Nature; 1999 Jan; 397(6717):315-23. PubMed ID: 9950424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 1-mediated induction of kappa-light chain synthesis and surface immunoglobulin expression on pre-B cells.
    Giri JG; Kincade PW; Mizel SB
    J Immunol; 1984 Jan; 132(1):223-8. PubMed ID: 6418798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells.
    Nagumo H; Agematsu K; Shinozaki K; Hokibara S; Ito S; Takamoto M; Nikaido T; Yasui K; Uehara Y; Yachie A; Komiyama A
    J Immunol; 1998 Dec; 161(12):6496-502. PubMed ID: 9862673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection.
    Guillonneau C; Louvet C; Renaudin K; Heslan JM; Heslan M; Tesson L; Vignes C; Guillot C; Choi Y; Turka LA; Cuturi MC; Anegon I; Josien R
    J Immunol; 2004 Feb; 172(3):1619-29. PubMed ID: 14734743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.